Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
POLITICO Healthcare PM: SCOTUS sinks pharma’s Medicare negotiation fight
Michael Lieberman, an attorney at Fairmark Partners who worked on the amicus brief for the advocacy group Patients For Affordable Drugs, said it is the end of the line for the six cases. “There are four other cases still pending in lower courts, some of them raising the same issues,” Lieberman said at a press […]
News and Reports
POLITICO: SCOTUS denies pharma challenge to Medicare negotiations
Michael Lieberman, an attorney at Fairmark Partners who worked on the amicus brief for the advocacy group Patients For Affordable Drugs, said it is the end of the line for the six cases. “There are four other cases still pending in lower courts, some of them raising the same issues,” Lieberman said at a press […]
Press Releases
WASHINGTON, D.C. — Following the Supreme Court’s decision this morning to decline petitions from AstraZeneca, Bristol Myers Squibb, Janssen, Novartis, Novo Nordisk, and Boehringer Ingelheim challenging the Medicare Drug Price Negotiation Program, Patients For Affordable Drugs and Public Citizen held a press briefing with a patient advocate and legal expert to discuss the implications for patients and the […]
Press Releases
The 2022 Prescription Drug Law Is Delivering Lasting Reductions in Prescription Drug Costs
WASHINGTON, D.C. — As debate continues around new proposals to lower prescription drug prices for Americans, one thing is clear: the 2022 prescription drug law is already helping to lower costs for millions of patients across the country. “The facts speak for themselves,” said Merith Basey, CEO of Patients For Affordable Drugs. “The Medicare drug price reforms are […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs has reached a major milestone: more than 40,000 vetted patient stories are now on our interactive map, documenting the real-world harm caused by high drug prices. There are stories from every state and every congressional district in the country and the map allows users to explore stories by disease, ZIP code, and more, offering […]
Press Releases
P4AD Responds to Regeneron MFN Deal and Gene Therapy Approval
WASHINGTON, D.C. — Regeneron is the latest drugmaker to reach a most-favored-nation (MFN) pricing agreement with the Trump administration, part of a broader set of voluntary deals aimed at bringing U.S. drug prices in line with those in other high-income countries. The company was the last of the 17 corporations that received letters in July […]
News and Reports
The Washington Times: Letter to the editor: High medication costs harm Latinos
In “Drug price controls jeopardize Latino patients, workers” (Web, March 31) Carlos Orta argued that efforts to lower drug prices would harm Hispanic communities, and he uses familiar pharmaceutical industry talking points to make his argument. Mr. Orta is right that Hispanic patients face disproportionately high rates of chronic disease, but that makes affordable medications even more […]
News and Reports
POLITICO Weekly Trade: Speaking of Tariffs
“There’s a real risk these tariffs will drive up costs and create more uncertainty for millions of patients already struggling to afford their medications,” Merith Basey, CEO of Patients for Affordable Drugs, said in a statement.